Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
British Journal of Clinical Pharmacology|January 1, 1995
The effect of tenidap on the anti-hypertensive efficacy of ACE inhibitors in patients treated for mild to moderate hypertensionW G Rapeport, V C Grimwood, J Hosie, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studiesM Aubier, H Lode, G Gialdroni-Grassi, et al.
Vaccine|October 16, 2016
Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypesNicola Logan, William G Dundon, Adama Diallo, et al.
Journal of Virology|September 23, 2000
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virusM J Hosie, T Dunsford, D Klein, et al.
Viruses|September 28, 2021
Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge StudyAndrea M Spiri, Marilisa Novacco, Marina L Meli, et al.
American Journal of Hypertension|October 6, 1999
Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?B Waeber, J M Detry, B Dahlöf, et al.
Vaccine|December 27, 2015
Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodiesNicola Logan, Elizabeth McMonagle, Angharad A Drew, et al.
Viruses|March 30, 2023
A Risk Factor Analysis of SARS-CoV-2 Infection in Animals in COVID-19-Affected HouseholdsEvelyn Kuhlmeier, Tatjana Chan, Marina L Meli, et al.
Journal of Virology|July 11, 1998
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virusB J Willett, K Adema, N Heveker, et al.
Italian Journal of Gastroenterology and Hepatology|June 6, 1998
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study GroupI Wiklund, K D Bardhan, S Müller-Lissner, et al.
Pageof 24